Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Establishing a Link between Zinc Homeostasis and Globin Gene Expression

Oluwaseun Olaiya, DO, Halyna Fedosyuk, MS, Lesya V Novikova, PhD, Matthew P Parker, BS, Kenneth R Peterson, PhD

Blood (2019) 134 (Supplement_1): 3578.

https://doi.org/10.1182/blood-2019-130758

Published: 2019

Journal Articles

Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL)

Pavan Bachireddy, MD, Nikolaos Barkas, PhD, Sachet A Shukla, PhD, Samuel Freeman, Liudmila Elagina, PhD, Vinhkhang N Nguyen, Kendell Clement, PhD, Ignaty Leshchiner, PhD, Jennifer R. Brown, MD PhD, Donna S Neuberg, ScD, Vincent T. Ho, MD, Robert J. Soiffer, MD, Jerome Ritz, MD PhD, Gad Getz, PhD, Edwin P. Alyea, III, MD, Peter Kharchenko, PhD, Catherine J. Wu, MD

Blood (2018) 132 (Supplement 1): 820.

https://doi.org/10.1182/blood-2018-99-116681

Published: 2018

Journal Articles

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Tongyuan Liu, MD, Dengju Li, MD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 5227.

https://doi.org/10.1182/blood-2018-99-115654

Published: 2018

Journal Articles

Role of miRNA in Micro-Environment Mediated Drug Resistance in Acute Promyelocytic Leukemia to Arsenic Trioxide

Saravanan Ganesan, MSc, Vairavan Lakshmanan, B.Tech, Hamenth Kumar Palani, MSc, Nithya Balasundaram, MSc, Ansu Abu Alex, MSc, Sachin David, MSc, Anu Korula, MD DM, Biju George, MD DM, Poonkuzhali Balasubramanian, MSc PhD, Harsha Gowda, PhD, Neha Vyas, PhD, Dasaradhi Palakodeti, PhD, Vikram Mathews, MD DM

Blood (2016) 128 (22): 5125.

https://doi.org/10.1182/blood.V128.22.5125.5125

Published: 2016

Journal Articles

Thrombomodulin Fusion Proteins Coupled to Human Erythrocytes Demonstrate Anti-Thrombotic and Anti-Inflammatory Activity

Carlos Hipolito Villa, MD PhD, Colin F Greineder, MDPhD, Ian Johnston, BS, Daniel Pan, PhD, Ronald Carnemolla, PhD, Douglas B. Cines, MD, Mortimer Poncz, MD, Don L. Siegel, MD, PhD,, Vladimir R Muzykantov, MDPhD

Blood (2015) 126 (23): 3493.

https://doi.org/10.1182/blood.V126.23.3493.3493

Published: 2015

Journal Articles

Atherogenic Trans Fatty Acid Alters Macrophage Lipid Metabolism with Sustained Dysregulation of Zinc Homeostasis

Lisa J Robinson, MD, Janelle R Zacherl, PhD, Stephanie J Mihalik, PhD, Irina L. Tourkova, PhD, Claudette M St Croix, PhD, Octavia M Peck-Palmer, PhD, Harry C Blair, MD

Blood (2014) 124 (21): 4112.

https://doi.org/10.1182/blood.V124.21.4112.4112

Published: 2014

Journal Articles

Histone Demethylase Inhibition As a Novel Therapeutic Strategy in Myeloma

Charlotte Pawlyn, MBBChir, Edward Hookway, MBBChir, Peter Cain, PhD, Laurynas Pliuskys, BSc, Martin F Kaiser, MD, Michael Bright, PhD, Lauren I Aronson, BSc(Hons), Alexander Murison, PhD, Morten Lindow, PhD, Susanna Obad, PhD, Henrik Oerum, PhD, Udo Opperman, PhD, Gareth J. Morgan, MD PhD, Faith E Davies, MD

Blood (2014) 124 (21): 2087.

https://doi.org/10.1182/blood.V124.21.2087.2087

Published: 2014

Journal Articles

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Rita Coutinho, MD, Aaron M. Newman, PhD, Guglielmo Rossignoli, PhD, William Day, MsC, Faridah Miraki-Moud, PhD, Tracy Chaplin, Jacek Marzec, Robert D. Petty, Sameena Iqbal, Janet Matthews, Ash A. Alizadeh, MD, PhD, John G Gribben

Blood (2012) 120 (21): 790.

https://doi.org/10.1182/blood.V120.21.790.790

Published: 2012

Journal Articles

Induction of Fetal Hemoglobin by Transcriptional Co-Activators MTF-1 and TSPYL1

Kenneth R Peterson, PhD, Flavia C Costa, PhD, Halyna Fedosyuk, Renee Neades, Johana Bravo de los Rios, Andrea Fonteles, Lesya Zelenchuk, Prarthana Dalal, Gabriella Maniscalco

Blood (2011) 118 (21): 353.

https://doi.org/10.1182/blood.V118.21.353.353

Published: 2011

Journal Articles

Functional and Biochemical Characterization of ZBTB11, a Novel Protein Critical for Myelopoiesis

Maria Cristina Keightley, PhD, BSc(Hons), Duncan P. Carradice, MBBS, FRCPA, FRACP, Graham Lieschke, PhD, MBBS, BMedSc, FRACP

Blood (2011) 118 (21): 1309.

https://doi.org/10.1182/blood.V118.21.1309.1309

Published: 2011

Journal Articles

GSK-3β Inhibitors In Overcoming Chemoresistance In Multiple Myeloma

Melissa A Kuhns, Matt Kalaycio, MD, Frederic J. Reu, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Venugopalan Cheriyath, Ph, D.

Blood (2010) 116 (21): 3009.

https://doi.org/10.1182/blood.V116.21.3009.3009

Published: 2010

Journal Articles

NF-κB Target Genes Activation Via Displacement of HDACs Bound to NF-κB p50 Homodimers by C/EBPα, Its AML Oncoproteins or C/EBPβ.

Ido Paz-Priel, M.D., Simone Houng, M.Eng., Julia E. Dooher, Ph.D., Alan D. Friedman, M.D.

Blood (2010) 116 (21): 3637.

https://doi.org/10.1182/blood.V116.21.3637.3637

Published: 2010

Journal Articles

C/EBPα or Its Leukemic Mutants Directly Activate nfkb1 Transcription and Displace HDAC1 or HDAC3 From Chromatin-Associated NF-κB p50 to Induce Anti-Apoptotic Genes.

Ido Paz-Priel, MD, Alan D. Friedman, MD

Blood (2009) 114 (22): 76.

https://doi.org/10.1182/blood.V114.22.76.76

Published: 2009

Journal Articles

PU.1 Epigenetically Represses the Expression of Metallothionein-1 Gene in Leukemia Cells

Shinichiro Takahashi, M.D., Ph.D., Mami Okada, Akemi Imoto, Masako Nakahara, Ph.D., Toshio Okazaki, Ph.D., Hideo Harigae, M.D., Ph.D.

Blood (2008) 112 (11): 1188.

https://doi.org/10.1182/blood.V112.11.1188.1188

Published: 2008

Journal Articles

Arsenic Trioxide Induces Up-Regulation of BMF and NOXA and Overcomes an Anti-Oxidative Response To Induce Apoptosis in Myeloma Cells.

Alejo A. Morales, PhD, Delia Gutman, M.S., Pedro J. Cejas, Ph.D., Kelvin P. Lee, M.D., Lawrence H. Boise, Ph.D.

Blood (2006) 108 (11): 3419.

https://doi.org/10.1182/blood.V108.11.3419.3419

Published: 2006

Journal Articles

Prognostic significance of metallothionein in B-cell lymphomas

Christian Bjørn Poulsen, Rehannah Borup, Niels Borregaard, Finn Cilius Nielsen, Michael Boe Møller, Elisabeth Ralfkiaer

Blood (2006) 108 (10): 3514–3519.

https://doi.org/10.1182/blood-2006-04-015305

Published: 2006

Journal Articles

Mitochondria Damage Leading to High Frequency of Lymphoma and Myeloproliferative Disorder in Transgenic Mice Overexpressing a Human 8-Oxoguanine DNA-Glycosylase Gene.

Qin Huang, MD, PhD, Haihong Zhang, M.D., Ph.D, Lawrence M. Weiss, M.D., Chun-Yang Fan, M.D., Ph.D

Blood (2006) 108 (11): 2246.

https://doi.org/10.1182/blood.V108.11.2246.2246

Published: 2006

Journal Articles

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Brad S. Kahl, MD, Ranjana Advani, MD, Neil Kay, MD, Izidore S. Lossos, MD, Andrew Evens, DO, Leo Gordon, MD, Richard A. Miller, MD, See-Chun Phan, MD

Blood (2005) 106 (11): 4758.

https://doi.org/10.1182/blood.V106.11.4758.4758

Published: 2005

Journal Articles

The Effect of Sickle Red Blood Cell Adhesion on Gene Expression in a PAF-Pre-Treated Microcirculatory Bed.

Ronald L. Nagel, MD, Dhananjay K. Kaul, PhD, Mary E. Fabry, PhD, Raouf Alami, PhD, Anne C. Rybicki, PhD

Blood (2005) 106 (11): 76.

https://doi.org/10.1182/blood.V106.11.76.76

Published: 2005

Journal Articles

Combination of Motexafin Gadolinium (MGd) with 90 Y Ibritumomab Tiuxetan (Zevalin®; 90 Yttrium-Zevalin) Radioimmunotherapy (RIT) Produces High Complete Remission Rates in Relapsed Rituximab-Refractory Follicular Non- Hodgkin’s Lymphoma (NHL).

Andrew M. Evens, DO, MS, David Patton, BS, Stewart Spies, MD, Smitha Sivaraman, PhD, M.Wayne Saville, MD, See Phan, MD, Richard Miller, MD, Leo I. Gordon, MD

Blood (2005) 106 (11): 2450.

https://doi.org/10.1182/blood.V106.11.2450.2450

Published: 2005

NARROW

Establishing a Link between Zinc Homeostasis and Globin Gene Expression

Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL)

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Role of miRNA in Micro-Environment Mediated Drug Resistance in Acute Promyelocytic Leukemia to Arsenic Trioxide

Thrombomodulin Fusion Proteins Coupled to Human Erythrocytes Demonstrate Anti-Thrombotic and Anti-Inflammatory Activity

Atherogenic Trans Fatty Acid Alters Macrophage Lipid Metabolism with Sustained Dysregulation of Zinc Homeostasis

Histone Demethylase Inhibition As a Novel Therapeutic Strategy in Myeloma

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Induction of Fetal Hemoglobin by Transcriptional Co-Activators MTF-1 and TSPYL1

Functional and Biochemical Characterization of ZBTB11, a Novel Protein Critical for Myelopoiesis

GSK-3β Inhibitors In Overcoming Chemoresistance In Multiple Myeloma

NF-κB Target Genes Activation Via Displacement of HDACs Bound to NF-κB p50 Homodimers by C/EBPα, Its AML Oncoproteins or C/EBPβ.

C/EBPα or Its Leukemic Mutants Directly Activate nfkb1 Transcription and Displace HDAC1 or HDAC3 From Chromatin-Associated NF-κB p50 to Induce Anti-Apoptotic Genes.

PU.1 Epigenetically Represses the Expression of Metallothionein-1 Gene in Leukemia Cells

Arsenic Trioxide Induces Up-Regulation of BMF and NOXA and Overcomes an Anti-Oxidative Response To Induce Apoptosis in Myeloma Cells.

Prognostic significance of metallothionein in B-cell lymphomas

Mitochondria Damage Leading to High Frequency of Lymphoma and Myeloproliferative Disorder in Transgenic Mice Overexpressing a Human 8-Oxoguanine DNA-Glycosylase Gene.

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

The Effect of Sickle Red Blood Cell Adhesion on Gene Expression in a PAF-Pre-Treated Microcirculatory Bed.

Combination of Motexafin Gadolinium (MGd) with 90 Y Ibritumomab Tiuxetan (Zevalin®; 90 Yttrium-Zevalin) Radioimmunotherapy (RIT) Produces High Complete Remission Rates in Relapsed Rituximab-Refractory Follicular Non- Hodgkin’s Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only